Xencor | XNCR - Net Income



Xencor reported $-30825000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Alnylam Pharmaceuticals USD -66277000 8.8M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Arrowhead Research USD -175241000 545.69M Jun/2025
AstraZeneca USD 2.45B 466M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Cytokinetics USD -134370000 27.01M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
MacroGenics USD -36250000 20.83M Jun/2025
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Xencor USD -30825000 17.59M Jun/2025